{"text": ["Novartis", "Stock", "Dives", "Alongside", "Pharma", "Peers", "Despite", "First-Quarter", "Beat"], "created_at": "2020-04-28 20:07:25"}
{"text": ["Novartis", "Stock", "Dives", "Alongside", "Pharma", "Peers", "Despite", "First-Quarter", "Beat"], "created_at": "2020-04-28 18:10:25"}
{"text": ["Novartis", "(NVS)", "Q1", "Earnings", "and", "Revenues", "Surpass", "Estimates"], "created_at": "2020-04-28 14:32:02"}
{"text": ["Biotech", "Heavyweight", "Amgen", "Enters", "The", "Coronavirus", "Arena", "\u2014", "But", "Is", "It", "A", "Buy?"], "created_at": "2020-04-28 13:00:53"}
{"text": ["The", "Zacks", "Analyst", "Blog", "Highlights:", "Intel,", "Novartis,", "Toyota", "Motor,", "Union", "Pacific", "and", "Biogen"], "created_at": "2020-04-28 12:51:12"}
{"text": ["Novartis", "Earnings", "Beat", "First-Quarter", "Views,", "Guidance", "Reaffirmed"], "created_at": "2020-04-28 12:10:25"}
{"text": ["Novartis", "CEO:", "We", "Feel", "We", "Can", "Maintain", "Full", "Year", "Guidance"], "created_at": "2020-04-28 07:36:08"}
{"text": ["Novartis", "sales,", "profits", "rise", "in", "first", "quarter", "on", "COVID-19", "buying", "rush"], "created_at": "2020-04-28 05:24:38"}
{"text": ["Novartis", "posts", "first-quarter", "sales,", "profit", "beat", "as", "COVID-19", "spurs", "prescriptions"], "created_at": "2020-04-28 05:24:11"}
